Paper36928856
The Role of fMRI in Drug Development: An Update.
Carmichael O. Adv Neurobiol, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. The Role of fMRI in Drug Development: An Update. Papers, record 36928856. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36928856
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Magnetic Resonance Imaging | Major topic |
| Brain | Major topic |
| Humans |
Source PubMed
References212
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32325112 | An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). | Regul Toxicol Pharmacol | 2020 | https://conductscience.org/library/papers/32325112 | PubMed |
| 2 | 28031269 | Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report. | Int J Neuropsychopharmacol | 2017 | https://conductscience.org/library/papers/28031269 | PubMed |
| 3 | 30056086 | New approaches in psychiatric drug development. | Eur Neuropsychopharmacol | 2018 | https://conductscience.org/library/papers/30056086 | PubMed |
| 4 | 32541893 | Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities. | Nat Rev Neurol | 2020 | https://conductscience.org/library/papers/32541893 | PubMed |
| 5 | 28145075 | Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry. | Hum Brain Mapp | 2017 | https://conductscience.org/library/papers/28145075 | PubMed |
| 6 | 28254585 | The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations. | J Pain | 2017 | https://conductscience.org/library/papers/28254585 | PubMed |
| 7 | 33908311 | Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)? | J Psychopharmacol | 2021 | https://conductscience.org/library/papers/33908311 | PubMed |
| 8 | 28664817 | Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials - Commentary. | Mult Scler | 2017 | https://conductscience.org/library/papers/28664817 | PubMed |
| 9 | 33781629 | A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders. | Eur Neuropsychopharmacol | 2021 | https://conductscience.org/library/papers/33781629 | PubMed |
| 10 | 21635967 | A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #1: processes and requirements. | Drug Discov Today | 2011 | https://conductscience.org/library/papers/21635967 | PubMed |
| 11 | 21477664 | A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #2: protocol optimization and best practices. | Drug Discov Today | 2011 | https://conductscience.org/library/papers/21477664 | PubMed |
| 12 | 29154758 | The role of fMRI in drug development. | Drug Discov Today | 2018 | https://conductscience.org/library/papers/29154758 | PubMed |
| 13 | 15707801 | On the nature of the BOLD fMRI contrast mechanism. | Magn Reson Imaging | 2004 | https://conductscience.org/library/papers/15707801 | PubMed |
| 14 | 14977420 | Interpreting the BOLD signal. | Annu Rev Physiol | 2004 | https://conductscience.org/library/papers/14977420 | PubMed |
| 15 | 16861326 | Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. | Br J Radiol | 2006 | https://conductscience.org/library/papers/16861326 | PubMed |
| 16 | 20471808 | Exploring the brain network: a review on resting-state fMRI functional connectivity. | Eur Neuropsychopharmacol | 2010 | https://conductscience.org/library/papers/20471808 | PubMed |
| 17 | 27766202 | Pharmaco fMRI: Determining the functional anatomy of the effects of medication. | Neuroimage Clin | 2016 | https://conductscience.org/library/papers/27766202 | PubMed |
| 18 | 32353718 | Current methods and new directions in resting state fMRI. | Clin Imaging | 2020 | https://conductscience.org/library/papers/32353718 | PubMed |
| 19 | 18172433 | Novel drugs and therapeutic targets for severe mood disorders. | Neuropsychopharmacology | 2008 | https://conductscience.org/library/papers/18172433 | PubMed |
| 20 | 20716397 | Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective. | Int J Neuropsychopharmacol | 2010 | https://conductscience.org/library/papers/20716397 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42021772 | Research progress and clinical application of functional magnetic resonance imaging in otolaryngology-head and neck diseases. | Front Neurol | 2026 | https://conductscience.org/library/papers/42021772 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36928856
GET https://conductscience.org/api/papers/v1/36928856/references?page=2